Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5

NCT00239369 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

713

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Fixed dose combination telmisartan 80 mg + HCTZ 25 mg
DRUG: Fixed dose combination telmisartan 80 mg + HCTZ 12.5 mg

Sponsor

Boehringer Ingelheim